Postnatal Slc26a4 gene therapy improves hearing and structural integrity in a hereditary hearing loss model
{{output}}
Mutations in SLC26A4 are the second most common cause of hereditary hearing loss in many Asian countries, leading to DFNB4, a condition characterized by progressive hearing loss and inner ear malformations. While gene therapy holds great potential, its postnat... ...
